When speaking about the Spanish healthcare environment, the complex process of introducing a new drug to the Spanish market is becoming of great importance. Therefore, it is necessary that those who are involved in the development and introduction of new drugs are knowledgeable about:
- How to access the Spanish market; the different levels of decision-making and who are the regulatory bodies that influence the approval and introduction of a new medicine.
- The new negotiation techniques for the innovative price and reimbursement agreements that can accelerate Spanish market access.
- How to use health economic tools in the introduction of new medicines in the Spanish market.
BioBasque (SPRI), Basque Biocluster and Insights in life Sciences (ilS) co-organize this training course in order to provide practical advice and detailed information about the complex Spanish market access process for new drugs. This course aims to share the latest innovative agreements in drug pricing and reimbursement, as well as the health economics tools that can be valuable during the introduction and launch of medicines into the Spanish market.
The training course is going to be delivered by Spanish top-notch representatives, professionals, and teachers from the areas of Market Access and Health Economics:
Dr. Pepi Hurtado, Partner in ilS
Dr. Pepi Hurtado has extensive experience in the pharmaceutical and biotechnology industry at global and national levels. She worked as senior consultant at IMS Health and as an independent consultant at her own company (DelScience). Prior to becoming a consultant, she had experience as a researcher both in academia and pharmaceutical industry. Additionally. Dr. Hurtado has a broad training in scientific fields, holds an MSc in Pharmacy (University of Barcelona) and a Ph.D. in Pharmaceutical Technology (University of London).
Dr. Itziar Escudero, Partner in ilS
Dr. Itziar Escudero has extensive experience in entrepreneurship, business development and strategic consulting in the pharmaceutical, biotech and medical device industries, both at national and international level. She worked for international firms such as Ernst & Young and PwC. Dr. Escudero holds an M.B.A. degree from the University of California, a Ph.D. in Biochemistry and Molecular Biology from the University of Barcelona, and a Masters in Chemical Sciences with a specialization in Biochemistry from Universidad Autónoma de Madrid.
Dr. Carme Pinyol, Pricing and Reimbursement and Market Access Senior Expert
Dr. Pinyol is graduated from Universitat Autònoma de Barcelona (UAB) with a degree in Medicine and Surgery and a Postgraduate in Medicine for the Pharmaceutical Industry, a Postgraduate degree in Statistical Techniques for the Life Sciences and a Postgraduate degree in clinical trial design for the life sciences. She holds a Master degree in Health Economics and Pharmacoeconomics from Universitat Pompeu Fabra (UPF), a Master degree in Social Healthcare from University of Castilla-La Mancha, an Executive Programme at ESADE, and currently she is completing her Ph.D. in Health Economics.
Dr. Pinyol, Founder and Director of INNOVA - Strategic consulting, worked for 23 years in different areas of the pharmaceutical industry (sales, training, marketing, discount medical economics, health, price and market access) and held various management positions. She was the Director of Pricing and Health Economics for two years in a multinational consultancy.